Financial Ratios Jiangxi GETO New Materials Corporation Limited
Equities
300986
CNE100004KX8
Business Support Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.20 CNY | -4.60% |
|
-0.54% | +196.96% |
| Jan. 15 | Jiangxi GETO New Materials's share trade to resume from January 16 | RE |
| Jan. 12 | Jiangxi GETO New Materials' trading to halt to verify share moves | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.3 | 5.1 | 3.92 | -0.01 | 1.47 | |||||
Return on Total Capital | 11.28 | 7.7 | 5.73 | -0.02 | 2.04 | |||||
Return On Equity % | 28.74 | 17.51 | 13.02 | -2.3 | 5.16 | |||||
Return on Common Equity | 27.78 | 17.1 | 13.49 | -3.12 | 4.87 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.98 | 32.13 | 30.73 | 21.46 | 25.35 | |||||
SG&A Margin | 15.73 | 11.87 | 11.08 | 12.79 | 11.14 | |||||
EBITDA Margin % | 58.68 | 65.71 | 51.53 | 41.61 | 40.49 | |||||
EBITA Margin % | 18.62 | 13.65 | 11.28 | 0.25 | 5.14 | |||||
EBIT Margin % | 18.49 | 13.5 | 11.04 | -0.04 | 4.89 | |||||
Income From Continuing Operations Margin % | 15.96 | 11.82 | 9.48 | -1.62 | 3.39 | |||||
Net Income Margin % | 15.05 | 11.1 | 9.19 | -2.02 | 2.92 | |||||
Net Avail. For Common Margin % | 15.05 | 11.1 | 9.19 | -2.02 | 2.92 | |||||
Normalized Net Income Margin | 8.31 | 6.43 | 5.42 | -2.41 | 0.34 | |||||
Levered Free Cash Flow Margin | 34.18 | 33.12 | 13.86 | 21.84 | 25.47 | |||||
Unlevered Free Cash Flow Margin | 35.75 | 34.05 | 15.39 | 23.9 | 27.97 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.63 | 0.61 | 0.57 | 0.5 | 0.48 | |||||
Fixed Assets Turnover | 1.02 | 1.08 | 1.11 | 1.09 | 1.17 | |||||
Receivables Turnover (Average Receivables) | 4.25 | 3.19 | 2.2 | 1.5 | 1.33 | |||||
Inventory Turnover (Average Inventory) | 4.4 | 5.02 | 5.14 | 6.36 | 6.6 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.67 | 0.81 | 0.9 | 1.09 | 0.99 | |||||
Quick Ratio | 0.47 | 0.57 | 0.69 | 0.93 | 0.85 | |||||
Operating Cash Flow to Current Liabilities | 0.09 | 0.13 | -0.12 | -0.2 | 0.01 | |||||
Days Sales Outstanding (Average Receivables) | 86.12 | 114.31 | 165.94 | 242.72 | 274.54 | |||||
Days Outstanding Inventory (Average Inventory) | 83.27 | 72.7 | 71.02 | 57.4 | 55.49 | |||||
Average Days Payable Outstanding | 135.16 | 119.09 | 133.81 | 146.65 | 147.63 | |||||
Cash Conversion Cycle (Average Days) | 34.23 | 67.92 | 103.15 | 153.47 | 182.4 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 91.61 | 47.47 | 80.95 | 121.98 | 135.25 | |||||
Total Debt / Total Capital | 47.81 | 32.19 | 44.74 | 54.95 | 57.49 | |||||
LT Debt/Equity | 25.7 | 17.63 | 30.58 | 60.32 | 56.71 | |||||
Long-Term Debt / Total Capital | 13.41 | 11.96 | 16.9 | 27.18 | 24.11 | |||||
Total Liabilities / Total Assets | 65.23 | 54.79 | 61.38 | 67.68 | 69.28 | |||||
EBIT / Interest Expense | 7.38 | 9.12 | 4.52 | -0.01 | 1.22 | |||||
EBITDA / Interest Expense | 23.42 | 44.6 | 21.43 | 12.99 | 10.26 | |||||
(EBITDA - Capex) / Interest Expense | 19.78 | 29.4 | 16.71 | 11.04 | 8.25 | |||||
Total Debt / EBITDA | 0.99 | 0.63 | 1.22 | 2.09 | 2.19 | |||||
Net Debt / EBITDA | 0.64 | 0.4 | 0.98 | 1.48 | 1.62 | |||||
Total Debt / (EBITDA - Capex) | 1.17 | 0.95 | 1.56 | 2.46 | 2.72 | |||||
Net Debt / (EBITDA - Capex) | 0.76 | 0.61 | 1.26 | 1.74 | 2.01 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 29.89 | 32.3 | 30.27 | 15.99 | 12.88 | |||||
Gross Profit, 1 Yr. Growth % | 16.77 | 16.41 | 24.61 | -19 | 33.34 | |||||
EBITDA, 1 Yr. Growth % | 44.16 | 48.11 | 2.15 | -6.37 | 8.87 | |||||
EBITA, 1 Yr. Growth % | 33.09 | -3.07 | 7.58 | -97.46 | 840.32 | |||||
EBIT, 1 Yr. Growth % | 33.38 | -3.36 | 6.57 | -100.39 | 2.04K | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 30.47 | -1.98 | 4.42 | -119.81 | -335.37 | |||||
Net Income, 1 Yr. Growth % | 28.72 | -2.39 | 7.89 | -125.5 | -262.69 | |||||
Normalized Net Income, 1 Yr. Growth % | 18.18 | 2.47 | 9.77 | -152.01 | -118.16 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 28.78 | -20.31 | -0.92 | -125 | -266.64 | |||||
Accounts Receivable, 1 Yr. Growth % | 73.88 | 72.33 | 101.12 | 50.58 | 6.23 | |||||
Inventory, 1 Yr. Growth % | 29.7 | 35.9 | 25.46 | -9 | 17.1 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 20.43 | 28.77 | 26.86 | 9.48 | 1.3 | |||||
Total Assets, 1 Yr. Growth % | 36.43 | 39.46 | 37.94 | 28.52 | 7.65 | |||||
Tangible Book Value, 1 Yr. Growth % | 38.03 | 65.72 | 13.62 | 9.2 | -3.31 | |||||
Common Equity, 1 Yr. Growth % | 32.33 | 78.37 | 13.55 | 7.45 | 1.31 | |||||
Cash From Operations, 1 Yr. Growth % | -333.89 | 72.2 | -230.53 | 110.97 | -106.44 | |||||
Capital Expenditures, 1 Yr. Growth % | -38.97 | 225.63 | -33.17 | -35.24 | 40.92 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 110.21 | 22.7 | -45.49 | 89.08 | 33.16 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 105.86 | 20.82 | -41.12 | 85.69 | 33.53 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 85.91 | -24.84 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 41.44 | 31.09 | 31.28 | 22.92 | 14.42 | |||||
Gross Profit, 2 Yr. CAGR % | 42.35 | 10.06 | 20.44 | 0.47 | 3.93 | |||||
EBITDA, 2 Yr. CAGR % | 65.29 | 46.14 | 23.01 | -2.19 | 1.41 | |||||
EBITA, 2 Yr. CAGR % | 66.99 | 13.61 | 2.16 | -83.45 | -22.86 | |||||
EBIT, 2 Yr. CAGR % | 67.16 | 13.5 | 1.48 | -93.51 | -23.85 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 62.44 | 13.09 | 1.17 | -54.44 | -31.72 | |||||
Net Income, 2 Yr. CAGR % | 60.18 | 12.09 | 2.62 | -47.51 | -35.59 | |||||
Normalized Net Income, 2 Yr. CAGR % | 59.06 | 10 | 6.05 | -24.75 | -71.07 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 52.37 | 1.34 | -11.26 | -50.25 | -35.45 | |||||
Accounts Receivable, 2 Yr. CAGR % | 79.24 | 73.1 | 86.17 | 74.03 | 26.48 | |||||
Inventory, 2 Yr. CAGR % | 18.7 | 32.76 | 30.58 | 6.85 | 3.23 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 32.61 | 24.53 | 27.81 | 17.85 | 5.31 | |||||
Total Assets, 2 Yr. CAGR % | 42.35 | 37.94 | 38.7 | 33.31 | 17.62 | |||||
Tangible Book Value, 2 Yr. CAGR % | 37.21 | 51.24 | 37.22 | 11.4 | 2.76 | |||||
Common Equity, 2 Yr. CAGR % | 32.87 | 53.64 | 42.32 | 10.46 | 4.33 | |||||
Cash From Operations, 2 Yr. CAGR % | 55.41 | 100.69 | 49.93 | 65.95 | -63.15 | |||||
Capital Expenditures, 2 Yr. CAGR % | 9.05 | 40.97 | 47.51 | -34.21 | -4.47 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 5.61 | 64.15 | -18.22 | -0.17 | 57.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 6.93 | 61.05 | -15.66 | 2.99 | 56.62 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | 18.21 | -13.31 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 54.92 | 38.32 | 30.81 | 25.97 | 19.48 | |||||
Gross Profit, 3 Yr. CAGR % | 52.46 | 28.1 | 14.71 | 5.52 | 10.41 | |||||
EBITDA, 3 Yr. CAGR % | 81.92 | 59.36 | 29.7 | 12.33 | 1.67 | |||||
EBITA, 3 Yr. CAGR % | 64.81 | 39.32 | 11.6 | -70.16 | -13.77 | |||||
EBIT, 3 Yr. CAGR % | 64.4 | 39.23 | 11.14 | -84.04 | -14.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 62.71 | 37.27 | 10.12 | -41.18 | -21.24 | |||||
Net Income, 3 Yr. CAGR % | 58.47 | 35.8 | 10.67 | -35.45 | -23.47 | |||||
Normalized Net Income, 3 Yr. CAGR % | 49.14 | 37.34 | 9.93 | -16.59 | -55 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 49 | 22.79 | 0.49 | -41.84 | -25.56 | |||||
Accounts Receivable, 3 Yr. CAGR % | 48.33 | 76.91 | 81.98 | 73.46 | 47.62 | |||||
Inventory, 3 Yr. CAGR % | 26.25 | 24.18 | 30.28 | 15.77 | 10.16 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 60.29 | 31.32 | 25.3 | 21.38 | 12.05 | |||||
Total Assets, 3 Yr. CAGR % | 53.53 | 41.38 | 37.94 | 35.33 | 24.15 | |||||
Tangible Book Value, 3 Yr. CAGR % | 46.04 | 46.12 | 37.49 | 27.16 | 6.26 | |||||
Common Equity, 3 Yr. CAGR % | 45.43 | 46.58 | 38.91 | 29.59 | 7.32 | |||||
Cash From Operations, 3 Yr. CAGR % | 73.8 | 60.82 | 73.88 | 68.01 | -43.83 | |||||
Capital Expenditures, 3 Yr. CAGR % | 14.71 | 57.03 | 9.92 | 12.11 | -15.2 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 86.44 | 12.66 | 13.68 | 6.93 | 9.46 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 87.03 | 12.94 | 15.16 | 8.62 | 11.9 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | 11.8 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 65.61 | 56.38 | 44.99 | 31.94 | 23.99 | |||||
Gross Profit, 5 Yr. CAGR % | 66.07 | 47.8 | 35.57 | 16.23 | 10.27 | |||||
EBITDA, 5 Yr. CAGR % | 91.96 | 92.73 | 55.57 | 31.1 | 17.55 | |||||
EBITA, 5 Yr. CAGR % | 61.81 | 59.66 | 36.13 | -40.57 | -3.7 | |||||
EBIT, 5 Yr. CAGR % | 61.87 | 59.3 | 35.54 | -59.17 | -4.46 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 58.3 | 59.58 | 34.55 | -11.7 | -8.98 | |||||
Net Income, 5 Yr. CAGR % | 55.04 | 58.25 | 33.19 | -7.16 | -10.85 | |||||
Normalized Net Income, 5 Yr. CAGR % | 51.05 | 57.06 | 30.11 | 7.96 | -35.66 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 40.27 | 43.68 | 21.12 | -14.5 | -15.83 | |||||
Accounts Receivable, 5 Yr. CAGR % | 43.72 | 51.95 | 62.44 | 75.75 | 57.33 | |||||
Inventory, 5 Yr. CAGR % | 70.43 | 63.08 | 27.96 | 16.93 | 18.7 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 79.63 | 62.32 | 46.41 | 25.76 | 16.89 | |||||
Total Assets, 5 Yr. CAGR % | 63.66 | 62.12 | 47.42 | 38.1 | 29.49 | |||||
Tangible Book Value, 5 Yr. CAGR % | 40.74 | 51.47 | 42.44 | 31.09 | 22.38 | |||||
Common Equity, 5 Yr. CAGR % | 42.34 | 55.7 | 44.18 | 30.9 | 23.88 | |||||
Cash From Operations, 5 Yr. CAGR % | 148.34 | 84.76 | 63.83 | 62.85 | -6.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | 35.12 | 87.84 | 26.85 | 10.88 | 3.92 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 94.92 | 46.89 | 35.27 | 7.34 | 28.72 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 99.48 | 47.23 | 37.15 | 8.85 | 29.44 |
Select your edition
All financial news and data tailored to specific country editions
















